<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39327436</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Mental illness and COVID-19 vaccination: a multinational investigation of observational &amp; register-based data.</ArticleTitle><Pagination><StartPage>8124</StartPage><MedlinePgn>8124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8124</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-52342-1</ELocationID><Abstract><AbstractText>Individuals with mental illness are at higher risk of severe COVID-19 outcomes. However, previous studies on the uptake of COVID-19 vaccination in this population have reported conflicting results. Using data from seven cohort studies (N = 325,298) included in the multinational COVIDMENT consortium, and the Swedish registers (N = 8,080,234), this study investigates the association between mental illness (defined using self-report measures, clinical diagnosis and prescription data) and COVID-19 vaccination uptake. Results from the COVIDMENT cohort studies were pooled using meta-analyses, the majority of which showed no significant association between mental illness and vaccination uptake. In the Swedish register study population, we observed a very small reduction in the uptake of both the first and second dose of a COVID-19 vaccine among individuals with vs. without mental illness; the reduction was however greater among those not using psychiatric medication. Here we show that uptake of the COVID-19 vaccine is generally high among individuals both with and without mental illness, however the lower levels of vaccination uptake observed among subgroups of individuals with unmedicated mental illness warrants further attention.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Barker</LastName><ForeName>Mary M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-5516-8615</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. mary.barker@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kõiv</LastName><ForeName>Kadri</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-5286-2014</Identifier><AffiliationInfo><Affiliation>Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Magnúsdóttir</LastName><ForeName>Ingibjörg</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-1983-6049</Identifier><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Milbourn</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4479-8635</Identifier><AffiliationInfo><Affiliation>Centre for Genomic and Experimental Medicine, Institute of Genetics &amp; Cancer, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0738-8859</Identifier><AffiliationInfo><Affiliation>PsychGen Centre for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Du</LastName><ForeName>Xinkai</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Modum Bad Psychiatric Hospital and Research Center, Oslo, Vikersund, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Gillian</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7845-1595</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herweijer</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gísladóttir</LastName><ForeName>Elísabet U</ForeName><Initials>EU</Initials><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Huiqi</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1127-0829</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovik</LastName><ForeName>Anikó</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6397-5011</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychology, Leiden University, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kähler</LastName><ForeName>Anna K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Archie</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0198-5078</Identifier><AffiliationInfo><Affiliation>Centre for Genomic and Experimental Medicine, Institute of Genetics &amp; Cancer, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feychting</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5101-0060</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauksdóttir</LastName><ForeName>Arna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joyce</LastName><ForeName>Emily E</ForeName><Initials>EE</Initials><Identifier Source="ORCID">0000-0001-9722-5596</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thordardottir</LastName><ForeName>Edda Bjork</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frans</LastName><ForeName>Emma M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffart</LastName><ForeName>Asle</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8042-8570</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Modum Bad Psychiatric Hospital and Research Center, Oslo, Vikersund, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mägi</LastName><ForeName>Reedik</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2964-6011</Identifier><AffiliationInfo><Affiliation>Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tómasson</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, University Hospital, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ásbjörnsdóttir</LastName><ForeName>Kristjana</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3263-3457</Identifier><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakobsdóttir</LastName><ForeName>Jóhanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreassen</LastName><ForeName>Ole A</ForeName><Initials>OA</Initials><Identifier Source="ORCID">0000-0002-4461-3568</Identifier><AffiliationInfo><Affiliation>NORMENT Centre, Division of Mental Health and Addiction, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Patrick F</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Sverre Urnes</ForeName><Initials>SU</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Modum Bad Psychiatric Hospital and Research Center, Oslo, Vikersund, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aspelund</LastName><ForeName>Thor</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-7998-5433</Identifier><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandlistuen</LastName><ForeName>Ragnhild Eek</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Norwegian Mother, Father and Child Cohort Study, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ask</LastName><ForeName>Helga</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0149-5319</Identifier><AffiliationInfo><Affiliation>PsychGen Centre for Genetic Epidemiology and Mental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PROMENTA Research Center, Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCartney</LastName><ForeName>Daniel L</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0003-3242-0360</Identifier><AffiliationInfo><Affiliation>Centre for Genomic and Experimental Medicine, Institute of Genetics &amp; Cancer, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebrahimi</LastName><ForeName>Omid V</ForeName><Initials>OV</Initials><Identifier Source="ORCID">0000-0002-8335-2217</Identifier><AffiliationInfo><Affiliation>PROMENTA Research Center, Department of Psychology, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehto</LastName><ForeName>Kelli</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdimarsdóttir</LastName><ForeName>Unnur A</ForeName><Initials>UA</Initials><Identifier Source="ORCID">0000-0001-5382-946X</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Public Health Sciences, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0892-5668</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3310-6456</Identifier><AffiliationInfo><Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>223273</GrantID><Agency>Norges Forskningsråd (Research Council of Norway)</Agency><Country /></Grant><Grant><GrantID>324620</GrantID><Agency>Norges Forskningsråd (Research Council of Norway)</Agency><Country /></Grant><Grant><GrantID>105668 and 138929</GrantID><Agency>NordForsk</Agency><Country /></Grant><Grant><GrantID>KAW 2021-0010/VC2021.0018</GrantID><Agency>Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)</Agency><Country /></Grant><Grant><GrantID>847776</GrantID><Agency>EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)</Agency><Country /></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>2022-00579</GrantID><Agency>Forskningsrådet om Hälsa, Arbetsliv och Välfärd (Swedish Research Council for Health, Working Life and Welfare)</Agency><Country /></Grant><Grant><GrantID>2021-05045 and 2021-05450, ALFGBG-938453, ALFGBG-971130, ALFGBG-978954</GrantID><Agency>Vetenskapsrådet (Swedish Research Council)</Agency><Country /></Grant><Grant><GrantID>105668</GrantID><Agency>NordForsk</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="Y">Mental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>EMF received speaker’s honoraria from Astra Zeneca. OAA is a consultant for Cortechs.ai, and received speaker’s honoraria from Janssen, Lundbeck, Sunovion, Otsuka. PFS is a shareholder and on the advisory committee of Neumora Therapeutics. FN owns some AstraZeneca shares. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39327436</ArticleId><ArticleId IdType="pmc">PMC11427681</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-52342-1</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-52342-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation. WHO Coronavirus (COVID-19) Dashboard 2023 Available from: https://covid19.who.int.</Citation></Reference><Reference><Citation>Tregoning, J. S., Flight, K. E., Higham, S. L., Wang, Z. &amp; Pierce, B. F. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat. Rev. Immunol.21, 626–636 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8351583</ArticleId><ArticleId IdType="pubmed">34373623</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, C. et al. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int. J. Infect. Dis.114, 252–260 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu, E. et al. A global database of COVID-19 vaccinations. Nat. Hum. Behav.5, 947–953 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33972767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Q. et al. Mapping global acceptance and uptake of COVID-19 vaccination: a systematic review and meta-analysis. Commun. Med.2, 113 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9465145</ArticleId><ArticleId IdType="pubmed">36101704</ArticleId></ArticleIdList></Reference><Reference><Citation>Plans-Rubió, P. Percentages of vaccination coverage required to establish herd immunity against SARS-CoV-2. Vaccines10, 736 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9144560</ArticleId><ArticleId IdType="pubmed">35632492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolini, F. et al. Risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 mortality in people with pre-existing mental disorders: an umbrella review. BMC psychiatry23, 1–12 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10026202</ArticleId><ArticleId IdType="pubmed">36941591</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson, S. F., et al. Adverse SARS-CoV-2-associated outcomes among people experiencing social marginalisation and psychiatric vulnerability: a population-based cohort study among 4, 4 million people. The Lancet Regional Health–Europe. 20, 100421 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9242846</ArticleId><ArticleId IdType="pubmed">35789954</ArticleId></ArticleIdList></Reference><Reference><Citation>Suffel, A. M. et al. Exploring the impact of mental health conditions on vaccine uptake in high-income countries: a systematic review. BMC Psychiatry23, 1–18 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9823258</ArticleId><ArticleId IdType="pubmed">36611145</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonkat, N., Fellendorf, F. T., Dalkner, N. &amp; Reininghaus, E. Z. Severe mental disorders and vaccinations–a systematic review. World J. Biol. Psychiatry23, 501–516 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35014937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson, S. F. et al. Vaccination against SARS-CoV-2 infection among vulnerable and marginalised population groups in Denmark: A nationwide population-based study. Lancet Regional Health-Eur.16, 100355 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8948003</ArticleId><ArticleId IdType="pubmed">35350631</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitan, D. T., Kridin, K., Cohen, A. D. &amp; Weinstein, O. COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study. Lancet Psychiatry8, 901–908 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342316</ArticleId><ArticleId IdType="pubmed">34364406</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisl, V. &amp; Vevera, J. COVID-19 vaccine uptake in mental healthcare users: Czech nationwide register study. Vaccine41, 5435–5440 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37479611</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, D.-W. et al. COVID-19 vaccination, incidence, and mortality rates among individuals with mental disorders in South Korea: A nationwide retrospective study. Asian J. psychiatry85, 103600 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10129338</ArticleId><ArticleId IdType="pubmed">37163942</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy, S. et al. Variations in COVID-19 vaccination uptake among people in receipt of psychotropic drugs: cross-sectional analysis of a national population-based prospective cohort. Br. J. Psychiatry221, 1–8 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35249568</ArticleId></ArticleIdList></Reference><Reference><Citation>Unnarsdóttir, A. B. et al. Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations. Int. J. Epidemiol.51, e108–e122 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8690101</ArticleId><ArticleId IdType="pubmed">35020900</ArticleId></ArticleIdList></Reference><Reference><Citation>De Picker, L. J. et al. Severe mental illness and European COVID-19 vaccination strategies. Lancet Psychiatry8, 356–359 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906735</ArticleId><ArticleId IdType="pubmed">33609450</ArticleId></ArticleIdList></Reference><Reference><Citation>European Union Agency for Fundamental Rights (FRA). Coronavirus pandemic in the EU – Fundamental Rights implications: National vaccine deployment: Estonia 2021 [Available from: https://fra.europa.eu/sites/default/files/fra_uploads/ee_report_on_national_vaccine_deployment.pdf.</Citation></Reference><Reference><Citation>Edinburgh Health and Social Care Partnership. COVID-19 vaccination programme priority groups 4 and 6 2021 [Available from: https://www.edinburghhsc.scot/covid-19vaccinationprogrammeprioritygroups46/.</Citation></Reference><Reference><Citation>Lawrence, D. &amp; Kisely, S. Inequalities in healthcare provision for people with severe mental illness. J. Psychopharmacol.24, 61–68 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951586</ArticleId><ArticleId IdType="pubmed">20923921</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles, L. W., Williams, N., Luthy, K. E. &amp; Eden, L. Adult vaccination rates in the mentally ill population: an outpatient improvement project. J. Am. Psychiatr. Nurses Assoc.26, 172–180 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">30866701</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, C. et al. Increasing COVID-19 vaccination rates among patients with serious mental illness: a pilot intervention study. Psychiatr. Serv.73, 1274–1277 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35414188</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus, P. et al. Cohort profile update: the Norwegian mother and child cohort study (MoBa). Int. J. Epidemiol.45, 382–388 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27063603</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer, R. L., Kroenke, K., Williams, J. B. &amp; Löwe, B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med.166, 1092–1097 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke, K., Spitzer, R. L. &amp; Williams, J. B. The PHQ‐9: validity of a brief depression severity measure. J. Gen. Intern. Med.16, 606–613 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Aluoja, A., Shlik, J., Vasar, V., Luuk, K. &amp; Leinsalu, M. Development and psychometric properties of the Emotional State Questionnaire, a self-report questionnaire for depression and anxiety. Nord. J. Psychiatry53, 443–449 (1999).</Citation></Reference><Reference><Citation>European Medicines Agency. EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU 2021 Available from: https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-janssen-authorisation-eu.</Citation></Reference><Reference><Citation>Hale, T. et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat. Hum. Behav.5, 529–538 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33686204</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw.36, 1–48 (2010).</Citation></Reference><Reference><Citation>Nyberg, F., et al. Swedish Covid-19 investigation for future insights–a population epidemiology approach using register linkage (SCIFI-PEARL). Clinic. Epidemiol. 649–659 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8331198</ArticleId><ArticleId IdType="pubmed">34354377</ArticleId></ArticleIdList></Reference><Reference><Citation>Krisinformation.se. Covid-19 vaccination begins on 27 December 2020 Available from: https://www.krisinformation.se/en/news/2020/december/vaccination-27-december.</Citation></Reference><Reference><Citation>Moghadas, S. M. et al. Evaluation of COVID-19 vaccination strategies with a delayed second dose. PLoS Biol.19, e3001211 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8092656</ArticleId><ArticleId IdType="pubmed">33882066</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan, H. et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol.173, 676–682 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21330339</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>